Alteration of Cellular Phenotype and Responses to Oxidative Stress by Manganese Superoxide Dismutase and a Superoxide Dismutase Mimic in RWPE-2 Human Prostate Adenocarcinoma Cells

Antioxidants and Redox Signaling

Volumn 6, Issue 3, 2004, Pages 513-522

  Zhong, Weixiong ^a,b   Yan, Tao ^c   Webber, Mukta M ^d   Oberley, Terry D ^a,b  

^a WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BUTHIONINE SULFOXIMINE; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR; ENZYME VARIANT; GLUTATHIONE; GLUTATHIONE DISULFIDE; MANGANESE SUPEROXIDE DISMUTASE; MANGANESE TETRAKIS(1 METHYL 4 PYRIDYL)PORPHYRINE PENTACHLORIDE; PROTEIN P21; SODIUM SELENITE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL; CELL FUNCTION; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; DNA TRANSFECTION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GROWTH RATE; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; WESTERN BLOTTING;

TRIXIS;

EID: 2442432474     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308604773934279     Document Type: Article

References (50)

1. Abate C, Patel L, Rauscher FJ 3d, and Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249: 1157-1161, 1990.
2. Abdulla M and Gruber P. Role of diet modification in cancer prevention. Biofactors 12: 45-51, 2000.
3. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, and Rhee SG. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272: 217-221, 1997.
4. Baker AM, Oberley LW, and Cohen MB. Expression of antioxidant enzymes in human prostatic adenocarcinoma. Prostate 32: 229-233, 1997.
5. Bello D, Webber MM, Kleinman HK, Wartinger DD, and Rhim JS. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis 18: 1215-1223, 1997.
6. 2/M DNA damage checkpoint during oxidative stress. Environ Mol Mutagen 33: 144-152, 1999.
7. Bostwick DG, Alexander EE, Singh R, Shan A, Qian J, Santella RM, Oberley LW, Yan T, Zhong W, Jiang X, and Oberley TD. Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer 89: 123-134, 2000.
8. Brooks JD, Metter EJ, Chan DW, Sokoll LJ, Landis P, Nelson WG, Muller D, Andres R, and Carter HB. Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 166: 2034-2038, 2001.
9. Church SL, Grant JW, Ridnour LA, Oberley LW, Swanson PE, Meltzer PS, and Trent JM. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci USA 90: 3113-3117, 1993.
10. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, and Taylor JR. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276: 1957-1963, 1996.
11. Combs GF Jr and Gray WP. Chemopreventive agents: selenium. Pharmacol Ther 79: 179-192, 1998.
12. Dalton TP, Shertzer HG, and Puge A. Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol 39: 67-101, 1999.
13. Day BJ, Fridovich I, and Crapo JD. Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury. Arch Biochem Biophys 347: 256-262, 1997.
14. Faulkner KM, Liochev SI, and Fridovich I. Stable Mn(III) porphyrins mimic superoxide dismutase in vitro and substitute for it in vivo. J Biol Chem 269: 23471-23476, 1994.
15. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol 10: 248-253, 1998.
16. Gardner PR, Nguyen DD, and White CW. Superoxide scavenging by Mn(II/III) tetrakis (1-methyl-4-pyridyl) porphyrin in mammalian cells. Arch Biochem Biophys 325: 20-28, 1996.
17. Jacobs EJ, Connell CJ, Patel AV, Chao A, Rodriguez C, Seymour J, McCullough ML, Calle EE, and Thun MJ. Vitamin C and vitamin E supplement use and colorectal cancer mortality in a large American Cancer Society cohort. Cancer Epidemiol Biomarkers Prev 10: 17-23, 2001.
18. Jiang C, Wang Z, Ganther H, and Lu J. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res 61: 3062-3070, 2001.
19. Kim KH, Rodriguez AM, Carrico PM, and Melendez JA. Potential mechanisms for the inhibition of tumor cell growth by manganese superoxide dismutase. Antioxid Redox Signal 3: 361-373, 2001.
20. Lee SH, Oe T, and Blair IA. Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 292: 2083-2086, 2001.
21. Levi F, Pasche C, Lucchini F, and La Vecchia C. Dietary intake of selected micronutrients and breast-cancer risk. Int J Cancer 91: 260-263, 2001.
22. Li N, Oberley TD, Oberley LW, and Zhong W. Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype. Prostate 35: 221-233, 1998.
23. Li S, Yan T, Yang JQ, Oberley TD, and Oberley LW. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res 60: 3927-3939, 2000.
24. Maramag C, Menon M, Balaji KC, Reddy PG, and Laxmanan S. Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability, and DNA synthesis. Prostate 32: 188-195, 1997.
25. McDermott JH. Antioxidant nutrients: current dietary recommendations and research update. J Am Pharm Assoc 40: 785-799, 2000.
26. Menon M, Maramag C, Malhotra RK, and Seethalakshmi L. Effect of vitamin C on androgen independent prostate cancer cells (PC3 and Mat-Ly-Lu) in vitro: involvement of reactive oxygen species-effect on cell number, viability and DNA synthesis. Cancer Biochem Biophys 16: 17-30, 1998.
27. Oberley TD and Oberley LW. Antioxidant enzyme levels in cancer. Histol Histopathol 12: 525-535, 1997.
28. Oberley TD, Zhong W, Szweda LI, and Oberley LW. Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate 44: 144-155, 2000.
29. Pfeiffer S, Schrammel A, Koesling D, Schmidt K, and Mayer B. Molecular actions of a Mn(III)porphyrin superoxide dismutase mimetic and peroxynitrite scavenger: reaction with nitric oxide and direct inhibition of NO synthase and soluble guanylyl cyclase. Mol Pharmacol 53: 795-800, 1998.
30. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, and Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 392: 559, 1998.
31. Qiu X, Forman HJ, Schonthal AH, and Cadenas E. Induction of p21 mediated by reactive oxygen species formed during the metabolism of aziridinylbenzoquinones by HCT116 cells. J Biol Chem 271: 31915-31921, 1996.
32. 2-dependent ERK1/2 activation. J Biol Chem 276: 14264-14270, 2001.
33. 2. Free Radic Biol Med 29: 801-813, 2000.
34. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, and Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science 179: 588-590, 1973.
35. Russo T, Zambrano N, Esposito F, Ammendola R, Cimino F, Fiscella M, Jackman J, O'Connor PM, Anderson CW, and Appella E. A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J Biol Chem 270: 29386-29391, 1995.
36. 2 cells. Int J Cancer 81: 820-828, 1999.
37. Spallholz JE, Shriver BJ, and Reid TW. Dimethyldiselenide and methylseleninic acid generate superoxide in an in vitro chemiluminescence assay in the presence of glutathione: implications for the anticarcinogenic activity of L-selenomethionine and L-Se-methylselenocysteine. Nutr Cancer 40: 34-41, 2001.
38. Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med 8: 583-599, 1990.
39. 2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
40. 2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1. J Biol Chem 270: 30334-30338, 1995.
41. Toledano MB and Leonard WJ. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci U S A 88: 4328-4332, 1991.
42. Venugopal M, Jamison JM, Gilloteaux J, Koch JA, Summers M, Hoke J, Sowick C, and Summers JL. Synergistic antitumour activity of vitamins C and K3 against human prostate carcinoma cell lines. Cell Biol Int 20: 787-797, 1996.
43. Vogt TM, Ziegler RG, Graubard BI, Swanson CA, Greenberg RS, Schoenberg JB, Swanson GM, Hayes RB, and Mayne ST. Serum selenium and risk of prostate cancer in U.S. blacks and whites. Int J Cancer 103: 664-670, 2003.
44. Weinberg WC and Denning MF. P21Waf1 control of epithelial cell cycle and cell fate. Crit Rev Oral Biol Med 13: 453-464, 2002.
45. Wenk J, Brenneisen P, Wlaschek M, Poswig A, Briviba K, Oberley TD, and Scharffetter-Kochanek K. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J Biol Chem 274: 25869-25876, 1999.
46. Yoshizawa K, Willett WC, Morris SJ, Stampfer MJ, Spiegelman D, Rimm EB, and Giovannucci E. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 90: 1219-1224, 1998.
47. Zhang HJ, Zhao W, Venkataraman S, Robbins ME, Buettner GR, Kregel KC, and Oberley LW. Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species. J Biol Chem 277: 20919-20926, 2002.
48. Zhong W and Oberley TD. Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line. Cancer Res 61: 7071-7078, 2001.
49. Zhong W, Oberley LW, Oberley TD, Yan T, Domann FE, and St. Clair DK. Inhibition of cell growth and sensitization to oxidative damage by overexpression of manganese superoxide dismutase in rat glioma cells. Cell Growth Differ 7: 1175-1186, 1996.
50. Zhong W, Oberley LW, Oberley TD, and St. Clair DK. Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene 14: 481-490, 1997.